Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gary Sender currently holds 13,313 shares of Nabriva Therapeutics Plc (NBRV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gary Sender has been a net seller of NBRV stock. They have purchased $25.6K and sold $1.9M worth of shares.
Gary Sender's most recent insider trade was on Jun 22, 2026, when they sold 13,313 shares at $0.00 per share.
Gary Sender serves as Executive at Nabriva Therapeutics Plc (NBRV). They have executed 33 insider transactions totaling $1.9M over their tenure at the company.
Gary Sender holds the position of Executive at Nabriva Therapeutics Plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Gary Sender has shown a selling trading pattern, with $25.6K in total purchases and $1.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Gary Sender was on Mar 8, 2021, when they sold $1.9M worth of SDGR shares. This transaction involved 28,775 shares at $66.55 per share.
Gary Sender currently owns 13,313 shares of Nabriva Therapeutics Plc (NBRV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gary Sender's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gary Sender has 33 Form 4 filings on record as an insider at Nabriva Therapeutics Plc.
Set alerts for Gary Sender and 40,000+ other insiders.